Gene · 6282
S100A11: S100 calcium binding protein A11
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. S100A11: S100 calcium binding protein A11. Genes, record 6282. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6282
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P31949 | Protein S100-A11 | 105 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents79
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 62528 | P31949 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2782 | P31949 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2782 | P31949 | Espacenet |
| EP 4549941 A1 | 2025-05-07 | 14 | P31949 | Espacenet |
| WO 2024252368 A2 | 2024-12-12 | 55 | P31949 | Espacenet |
| KR 1020240158140 A | 2024-11-04 | 6 | P31949 | Espacenet |
| US 11988676 B2 | 2024-05-21 | 56 | P31949 | Espacenet |
| JP 2024038290 A | 2024-03-19 | 56 | P31949 | Espacenet |
| JP 2024509530 A | 2024-03-04 | 28 | P31949 | Espacenet |
| JP 2024009871 A | 2024-01-23 | 41 | P31949 | Espacenet |
1 to 10 of 79
See all 79 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants826
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | S100A11 papers | Newest fiscal year |
|---|---|---|---|
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 4 | 2025 |
| P30AR070155 | RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 3 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 3 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 3 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 3 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 2 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
1 to 10 of 826Source NIH's project files
See all 826 nih grantsPapers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electrochemical immunosensor-enabled liquid biopsy of extracellular vesicles for diagnosis of metabolic dysfunction-associated steatohepatitis. | medRxiv | 2026 | 42818423 | PubTator, text mining | PubMed |
| Integrated plasma proteomic and metabolomic profiling demonstrated specific proteins and bile acids remodeling after liver transplantation of children with biliary atresia. | Biochim Biophys Acta Proteins Proteom | 2026 | 42777789 | PubTator, text mining | PubMed |
| Amplification-Driven S100A11 Overexpression in Hepatocellular Carcinoma Is Associated with Metabolic Reprogramming, ECM Remodelling, and Immune Evasion: A Pan-Cancer Genomic Study. | Cancers (Basel) | 2026 | 42738370 | PubTator, text mining | PubMed |
| Olink proteomics identifies serum protein biomarkers and an age-stratified diagnostic model for diabetes in Chinese patients. | Front Endocrinol (Lausanne) | 2026 | 42718750 | PubTator, text mining | PubMed |
| S100A11 regulates hepatic cholesterol metabolism and promotes steatohepatitis via noncanonical SREBP2 signaling. | J Clin Invest | 2026 | 42550612 | PubTator, text mining | PubMed |
| Proteomic and amino acid profiling of SK-MEL-30 melanoma reveals metabolic and structural changes. | Anal Biochem | 2026 | 42470940 | PubTator, text mining | PubMed |
| S100A16 as a potential therapeutic target in sepsis-induced acute lung injury. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42456993 | PubTator, text mining | PubMed |
| Lactylation-driven stabilization of the S100A11/ANXA2 complex promotes pancreatic cancer metastasis. | Cell Biol Toxicol | 2026 | 42432264 | PubTator, text mining | PubMed |
| Lactylation shields S100A11 from degradation to promote gastric cancer metastasis. | Cell Oncol (Dordr) | 2026 | 42423863 | PubTator, text mining | PubMed |
| Functional switching of S100A11 in cancer: An exploration based on molecular mechanisms. | Crit Rev Oncol Hematol | 2026 | 42285330 | PubTator, text mining | PubMed |
1 to 10 of 1,617
See all 1,617 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6282
GET https://conductscience.org/api/genes/v1/6282/patents?page=2